Cerebras Systems (CBRS), the AI infrastructure company known for its wafer-scale engine chips, surged 8.09% in Monday's session to approximately $179.90, rebounding sharply from Friday's close of $166.43. The move marks a decisive recovery for a stock that had fallen roughly 20% the prior week and had just closed at its lowest level since its May 2026 initial public offering. Markets attributed the rally primarily to public comments from OpenAI Chief Executive Sam Altman, who reassured investors that the two companies remain closely aligned despite recent reports questioning the depth of their partnership.
The day's dominant driver was a late-Friday social media post from OpenAI CEO Sam Altman addressing what he described as "some speculation" about the relationship. "Cerebras is a close partner, and we have a deep engagement pushing on the frontiers of speed," Altman wrote. The comments directly countered a research report suggesting OpenAI's newly unveiled GPT-6.1 Sol "Ultrafast" model would run on Nvidia GPUs rather than Cerebras hardware — a development that had rattled investors and fueled last week's sharp decline.
Because OpenAI is Cerebras's most important customer by contracted backlog, anchored by a multi-year agreement to deploy 750 megawatts of computing capacity, any signal about the durability of that relationship carries outsized weight. Altman's public endorsement helped reverse bearish sentiment and sparked a relief rally across the session.
The recovery was also supported by a more constructive tone from Wall Street. On Friday, Freedom Capital upgraded CBRS to Buy from Hold, calling the selloff an overreaction and pointing to a multi-year environment in which AI compute demand is expected to outstrip supply. Separately, Jefferies initiated coverage with an Outperform rating, signaling that analysts see the pullback as a potential entry point rather than a structural deterioration in the business.
Monday's gain should be viewed in the context of the prior week's pressure. Beyond the Nvidia-related report, the stock faced an expanded float as a post-IPO lockup release made roughly 19.4 million additional shares eligible for sale, and filings showed senior executives planned to sell portions of their holdings. Those supply dynamics compounded the fundamental concerns and pushed shares to their lowest close since the IPO. The current rally therefore represents a partial correction of that decline, with the stock still trading below its $185 offering price and well off its post-debut highs.
Trading was notably active as investors repositioned following Altman's comments and the analyst upgrades. The move coincided with a sharp shift in retail sentiment, which flipped to extremely bullish, and aligned with a broader easing of pressure on AI-infrastructure names that had been caught in the sector's recent volatility. Even so, the rebound remains a single-stock recovery driven by company-specific news rather than a broad market catalyst, leaving the stock below key technical reference points established around its IPO price.
Investors will now focus on whether Cerebras can convert the renewed optimism into fundamental confirmation. Upcoming earnings will be closely watched, particularly for updates on remaining performance obligations, gross-margin trajectory, and the pace at which new power and manufacturing capacity comes online. The company's aggressive revenue-growth targets hinge on execution, and additional lockup tranches are scheduled in the weeks ahead, which could reintroduce supply pressure. The competitive landscape also remains a central risk, as Nvidia and other rivals continue to contest the high-speed AI inference market that Cerebras targets.
Traders seeking a systematic approach to fast-moving AI stocks may find value in Tickeron's Trending AI Robots page. Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this curated section. Bots vary by strategy, timeframe, performance metrics, and traded symbols, allowing users to explore approaches aligned with their own goals. Explore the Trending AI Robots to see which strategies are leading the market today.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CBRS saw its Momentum Indicator move below the 0 level on September 30, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 8 similar instances where the indicator turned negative. In 8 of the 8 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for CBRS turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 1 similar instances when the indicator turned negative. In 1 of the 1 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
CBRS moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CBRS entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
CBRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 31 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.876) is normal, around the industry mean (6.022). P/E Ratio (-23.805) is within average values for comparable stocks, (20.769). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.761). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (63.694) is also within normal values, averaging (45.794).
The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. CBRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Semiconductors